Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma

    Tag: pharma

    You Searched For "pharma"
    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Medical Dialogues Bureau13 July 2019 9:32 AM IST
    SYMJEPI is a small, single-dose, pre-filled syringe and device combination as an alternative to epinephrine auto-injectors for the emergency treatment...
    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    Medical Dialogues Bureau12 July 2019 11:48 AM IST
    Romiplostim is one of the most efficacious agents with proven long-term benefits in chronic ITP, a release here said.Mumbai: Pharma Major, Intas...
    Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

    Piramal cuts short-term borrowings, reduces dependence on CPs as NBFC crisis lingers

    Medical Dialogues Bureau12 July 2019 9:15 AM IST
    Piramal Enterprises chairman Ajay Piramal in his address to the shareholders in the FY19 annual report said the company continues to build resilience...
    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Medical Dialogues Bureau12 July 2019 9:10 AM IST
    Established in 1987 and headquartered in California, Gilead Sciences is one of the top 10 pharmaceutical companies in the world. As a pioneer in...
    Trump administration scraps key plan to reduce US drug prices

    Trump administration scraps key plan to reduce US drug prices

    Medical Dialogues Bureau12 July 2019 9:00 AM IST
    The decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Medical Dialogues Bureau9 July 2019 12:49 PM IST
    Mumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...
    Oklahoma judge denies motion to end case against drugmaker JnJ

    Oklahoma judge denies motion to end case against drugmaker JnJ

    Medical Dialogues Bureau9 July 2019 9:00 AM IST
    District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
    Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

    Drug Alert: CDSCO declares 26 drug samples as sub-standard in quality in random sampling; Details

    Farhat Nasim8 July 2019 4:16 PM IST
    New Delhi: Apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has declared more than a dozen drugs as sub-standard in...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 1:32 PM IST
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Licenses of over 50 chemist shops scrapped for Running without pharmacist

    Licenses of over 50 chemist shops scrapped for Running without pharmacist

    Farhat Nasim7 July 2019 5:05 PM IST
    Agra: Coming down heavily on chemist stores functioning without a pharmacist, the district drug administration has recently cancelled licenses of over...
    SAARC nations favour India-based Haslab for Homoeopathic Medicines

    SAARC nations favour India-based Haslab for Homoeopathic Medicines

    Medical Dialogues Bureau6 July 2019 9:45 AM IST
    Haslab as they are known in the homoeopathy market, they provide various forms of homoeopathic products like eye drops, homoeopathic complex tablets,...
    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche

    Medical Dialogues Bureau6 July 2019 9:15 AM IST
    Xofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok